Related Experiment Video
Updated: Jan 31, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
The relationship between obesity subtypes based on BMI and cardio-cerebrovascular disease
Xin Chen1, Guoping Gui2, Wen Ji2
1Department of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, 215123, China.
Abstract:
The purpose of this study was to identify the effects of various obesity phenotypes and metabolic abnormalities on cardio-cerebrovascular disease. We performed a large-scale, cross-sectional study including 10,089 participants aged ≥18 years in the National High-Technology district of Suzhou, China, from March 2016 to April 2016. Cardio-cerebrovascular disease included stroke and coronary heart disease. The prevalence rates of cardio-cerebrovascular disease among people with normal weight, overweight, and obesity in the unhealthy metabolism subgroup were higher than those among the three BMI groups in the healthy metabolism subgroup. Multivariate logistic regression analyses showed that after adjustment, the odds ratio (OR) of metabolically healthy obesity (MHO) with cardio-cerebrovascular disease was not statistically significant and that metabolically unhealthy obesity (MUO) was statistically associated with cardio-cerebrovascular disease, with an OR of 2.106 (1.294-3.429) in Model 1 and 3.043 (1.510-6.133) in Model 2. This study also found that regardless of whether in Model 1 or Model 2, the number of participants with MHO was much lower than that of those with MUO. Therefore, the obese population usually had metabolic abnormalities. Although MHO was not statistically associated with cardio-cerebrovascular disease, obesity should be controlled along with metabolic abnormalities to reduce the risk of cardio-cerebrovascular disease.
Related Concept Videos
Obesity
Relationship Formation
Ending Relationships
Relationship Growth
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...

